Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Berend R Beumer"'
Autor:
Berend R Beumer, Wojciech G Polak, Robert A de Man, Herold J Metselaar, David van Klaveren, Jeremy Labrecque, Jan NM IJzermans
Publikováno v:
JHEP Reports, Vol 5, Iss 2, Pp 100629- (2023)
Background & Aims: When listing for liver transplantation, one can transplant as soon as possible or introduce a test-of-time to better select patients, as the tumor’s biological behavior is observed. Knowing the degree of harm caused by time itsel
Externí odkaz:
https://doaj.org/article/7afaa9b68aef4d5eaa7d3b588ca61196
Autor:
Berend R. Beumer, Jeroen L.A. vanVugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Malgorzata Nowosad, William Bennet, Emmanouil Tsochatzis, Evangelia Koutli, Fariba Abbassi, Marco P.A.W. Claasen, Manuela Merli, Joanne O'Rourke, Martina Gambato, Alberto Benito, Avik Majumdar, Ek Khoon Tan, Maryam Ebadi, Aldo J. Montano‐Loza, Marina Berenguer, Herold J. Metselaar, Wojciech G. Polak, Vincenzo Mazzaferro, Jan N.M. IJzermans, Collaborators
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 5, Pp 2373-2382 (2022)
Abstract Background Access to the liver transplant waitlist for patients with hepatocellular carcinoma (HCC) depends on tumour presentation, biology, and response to treatments. The Milan Criteria (MC) represent the benchmark for expanded criteria th
Externí odkaz:
https://doaj.org/article/09a5ef2067314d928baf0c5a0b245f29
Autor:
Marco P.A.W. Claasen, Tommy Ivanics, Berend R. Beumer, Roeland F. de Wilde, Wojciech G. Polak, Gonzalo Sapisochin, Jan N.M. IJzermans
Publikováno v:
JHEP Reports, 5(6):100745. Elsevier
Background & Aims: Management of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is not well-defined. Therefore, we evaluated the management of cHCC-CCA using an online hospital-wide multicentre survey sent to expert centres. Methods: A survey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b385ea51547e0ddd4d9474aefc94bdb
http://www.scopus.com/inward/record.url?scp=85158817798&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85158817798&partnerID=8YFLogxK
Autor:
Boris Galjart, Stefan Buettner, Berend R. Beumer, Jeroen L.A. van Vugt, Jan N. M. IJzermans, Robert A. de Man, Bas Groot Koerkamp
Publikováno v:
European Journal of Surgical Oncology. 48:492-499
Background Many prognostic models for Hepatocellular Carcinoma (HCC) have been developed to inform patients and doctors about individual prognosis. Previous reviews of these models were qualitative and did not assess performance at external validatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3219a719e752b201497a2f47e09189d8
https://doi.org/10.1016/j.ejso.2021.09.012
https://doi.org/10.1016/j.ejso.2021.09.012
Autor:
Jan N. M. IJzermans, Ewout W. Steyerberg, Stefan Buettner, Takahito Yagi, Toshiyoshi Fujiwara, Yuzo Umeda, Kosei Takagi, Bastiaan Vervoort, Berend R. Beumer
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, 28(13), 8211-8220. SPRINGER
Annals of Surgical Oncology, 28(13), 8211-8220. Springer New York
Annals of Surgical Oncology, 28(13), 8211-8220. SPRINGER
Annals of Surgical Oncology, 28(13), 8211-8220. Springer New York
Background This study aimed to assess the performance of the pre- and postoperative early recurrence after surgery for liver tumor (ERASL) models at external validation. Prediction of early hepatocellular carcinoma (HCC) recurrence after resection is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a7ac9b213d5b2de59b60a74f07a4a8
http://europepmc.org/articles/PMC8591001
http://europepmc.org/articles/PMC8591001
Autor:
Timothy M. Pawlik, Berend R. Beumer, Casper H.J. van Eijck, Bas Groot Koerkamp, Marjolein Y.V. Homs, Stefan Büttner, Wojciech G. Polak, Jeroen L.A. van Vugt, Ewout W. Steyerberg, Jan N. M. IJzermans, Jeroen de Jonge, Lydi M.J.W. van Driel, Boris Galjart
Publikováno v:
HPB, 23(1), 25-36. John Wiley & Sons Inc.
HPB, 23(1), 25-36. ELSEVIER SCI LTD
HPB, 23(1), 25-36. ELSEVIER SCI LTD
Background The objective of this systematic review was to evaluate the performance of prognostic survival models for intrahepatic cholangiocarcinoma (iCCA) when validated in an external dataset. Furthermore, it sought to identify common prognostic fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5410c0d4e7b4f2dd0682785ba4fb8c29
https://doi.org/10.1016/j.hpb.2020.07.007
https://doi.org/10.1016/j.hpb.2020.07.007
Autor:
Peter B. Vermeulen, Roeland F. de Wilde, Berend R. Beumer, Cornelis Verhoef, Dave Sprengers, Pieter M. H. Nierop, Yannick M. Meyer, Diederik J. Höppener, Michail Doukas, Jan N. M. IJzermans
Publikováno v:
HPB
HPB, 24(4), 507-515. John Wiley & Sons Inc.
HPB, 24(4), 507-515. John Wiley & Sons Inc.
Background: Microvascular invasion (MVI) is an established prognosticator in hepatocellular carcinoma (HCC). Histopathological growth patterns (HGPs) classify the invasive margin of hepatic tumors, with superior survival observed for the desmoplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e45934459a9e5327ff4b32713b2480
Autor:
Hans Rabl, Ken Ichi Okada, Matthew H.G. Katz, Bassel F. El-Rayes, Stefan Buettner, Song Cheol Kim, Niek A. Peters, Mary Dillhoff, Christoph Tinchon, Sing Yu Moorcraft, Andrew H. Ko, Eran van Veldhuisen, Khurum Khan, Geertjan van Tienhoven, Bas Groot Koerkamp, Jill Lacy, Alessandro Paniccia, Sunhee S. Kim, Marjolein Y.V. Homs, Philippe Bachellier, Colin J. McKay, Parag J. Parikh, Pietro Addeo, Jessica M. Frakes, Andrea Wang-Gillam, Stephen Clarke, Mustafa Suker, Matthew J. Weiss, Marc G. Besselink, Ammar A. Javed, Quisette P. Janssen, Berend R. Beumer, Peter J. Hosein, Nathan Bahary, Eric A. Mellon, Ian Chau, Casper H.J. van Eijck, Martin D. McCarter, Kyu Pyo Kim, Nigel B. Jamieson, Georgios A. Margonis, Derek Grose, Johanna W. Wilmink, Maria Antonietta Bali, Hiroki Yamaue, Tanios Bekaii-Saab, Jaswinder S. Samra, Brian A. Boone
Publikováno v:
Journal of the National Cancer Institute, 111(8), 782-794. Oxford University Press
Journal of the National Cancer Institute, 111(8):djz073, 782-794. Oxford University Press
J Natl Cancer Inst
Journal of the National Cancer Institute, 111(8):djz073, 782-794. Oxford University Press
J Natl Cancer Inst
Background FOLFIRINOX is a standard treatment for metastatic pancreatic cancer patients. The effectiveness of neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer (BRPC) remains debated. Methods We performed a systematic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::638f5617903ac1be3ebf8a6a862b06a2
https://doi.org/10.1093/jnci/djz073
https://doi.org/10.1093/jnci/djz073
Autor:
Stefan Buettner, Kosei Takagi, Berend R. Beumer, Bastiaan Vervoort, Ewout W. Steyerberg, Yuzo Umeda, Toshiyoshi Fujiwara, Jan N. M. IJzermans, Takahito Yagi
Publikováno v:
Annals of Surgical Oncology, 28, 505-506. Springer New York
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc293fdb7b6411e6ef4b5414cf961e11
https://doi.org/10.1245/s10434-021-10132-9
https://doi.org/10.1245/s10434-021-10132-9
Autor:
Roeland F. de Wilde, Robert A. de Man, Jan N. M. IJzermans, Berend R. Beumer, Herold J. Metselaar, Wojciech G. Polak
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3730, p 3730 (2021)
Cancers, Vol 13, Iss 3730, p 3730 (2021)
Simple Summary For patients with early-stage hepatocellular carcinoma, it is important to know whether liver transplantation offers a survival benefit over liver resection. Patients receiving transplantation often have different characteristics in te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc1c864d9b9c1067b3b1ccf7b3a0c4c
https://doi.org/10.3390/cancers13153730
https://doi.org/10.3390/cancers13153730